Date: 2016-02-22
Type of information: Resignation
Compound:
Company: ALK Abello (Denmark)
Therapeutic area: Allergic diseases
Type agreement: resignation
Action mechanism:
Disease:
Details: * On February 22, 2016, ALK announced that Jens Bager will resign as President and CEO. The search for a new CEO will be initiated immediately. In the meantime, Steen Riisgaard will be Chairman of the Board with extended operational responsibilities, and will in his role act as day-to-day leader of the company.There will be no other changes to ALK's Board of Management consisting of Henrik Jacobi, EVP Research & Development, Flemming Pedersen, CFO, Søren Niegel, EVP Commercial Operations and Helle Skov, EVP Product Supply.
Financial terms:
Latest news:
